Cargando…

Pimecrolimus cream in the management of patients with atopic eczema

Atopic eczema is a common pediatric skin disorder. This review examines the use of pimecrolimus cream in the treatment of acute and chronic stages of the disease. The standard therapy is the treatment of acute flares with topical medications including pimecrolimus. The use of pimecrolimus cream for...

Descripción completa

Detalles Bibliográficos
Autor principal: Spergel, Jonathan M
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047932/
https://www.ncbi.nlm.nih.gov/pubmed/21436971
_version_ 1782199102180687872
author Spergel, Jonathan M
author_facet Spergel, Jonathan M
author_sort Spergel, Jonathan M
collection PubMed
description Atopic eczema is a common pediatric skin disorder. This review examines the use of pimecrolimus cream in the treatment of acute and chronic stages of the disease. The standard therapy is the treatment of acute flares with topical medications including pimecrolimus. The use of pimecrolimus cream for the first sign and symptoms of atopic eczema reduces the occurrence of flares as defined by the need for topical corticosteroids. The side effects of pimecrolimus cream are mild without any increase of infections or systemic immune suppression.
format Text
id pubmed-3047932
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-30479322011-03-23 Pimecrolimus cream in the management of patients with atopic eczema Spergel, Jonathan M Clin Cosmet Investig Dermatol Review Atopic eczema is a common pediatric skin disorder. This review examines the use of pimecrolimus cream in the treatment of acute and chronic stages of the disease. The standard therapy is the treatment of acute flares with topical medications including pimecrolimus. The use of pimecrolimus cream for the first sign and symptoms of atopic eczema reduces the occurrence of flares as defined by the need for topical corticosteroids. The side effects of pimecrolimus cream are mild without any increase of infections or systemic immune suppression. Dove Medical Press 2009-05-19 /pmc/articles/PMC3047932/ /pubmed/21436971 Text en © 2009 Spergel, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Spergel, Jonathan M
Pimecrolimus cream in the management of patients with atopic eczema
title Pimecrolimus cream in the management of patients with atopic eczema
title_full Pimecrolimus cream in the management of patients with atopic eczema
title_fullStr Pimecrolimus cream in the management of patients with atopic eczema
title_full_unstemmed Pimecrolimus cream in the management of patients with atopic eczema
title_short Pimecrolimus cream in the management of patients with atopic eczema
title_sort pimecrolimus cream in the management of patients with atopic eczema
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047932/
https://www.ncbi.nlm.nih.gov/pubmed/21436971
work_keys_str_mv AT spergeljonathanm pimecrolimuscreaminthemanagementofpatientswithatopiceczema